Search Within

Andrew Lassman

Formats
  1. Journal Article (63)
  2. Meeting Abstract (43)
  3. Book Section (5)
Groups
  1. Tow Center for Developmental Oncology (TCDO) (51)
  2. Epidemiology and Biostatistics (29)
  3. Biostatistics Service (28)
  4. Population Sciences Research Program (26)
  5. GSK Faculty (20)
  6. Radiology, Department of (20)

More Groups

People
  1. Lauren Abrey (49)
  2. Lisa De Angelis (49)
  3. Katherine Panageas (25)
  4. Craig Nolan (19)
  5. Igor Gavrilovic (18)
  6. Adilia Hormigo (16)

More People

Years
  1. 2020 (1)
  2. 2019 (2)
  3. 2017 (1)
  4. 2015 (2)
  5. 2014 (3)
  6. 2013 (5)

More Years

Publications
  1. Neuro-Oncology (38)
  2. Journal of Clinical Oncology (21)
  3. Journal of Neuro-Oncology (14)
  4. Clinical Cancer Research (4)
  5. International Journal of Radiation Oncology, Biology, Physics (4)
  6. Neurology (3)

More Publications

Publishers
  1. Oxford University Press (38)
  2. American Society of Clinical Oncology (21)
  3. Springer (19)
  4. Elsevier Inc. (8)
  5. American Association for Cancer Research (5)
  6. Lippincott Williams & Wilkins (4)

More Publishers

Results (111)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II trial of vinorelbine and intensive temozolomide for patients with recurrent or progressive brain metastases
    Journal Article

    Iwamoto, F. M.; Omuro, A. M.; Raizer, J. J.; Nolan, C. P.; Hormigo, A. L.; Lassman, A. B.; Gavrilovic, I. T.; Abrey, L. E.
    Journal of Neuro-Oncology (2008)

    Fulltext@MSK | Save
  • Clinical outcome of glioblastoma multiforme patients with long-term survival
    Meeting Abstract

    Yoon, H.; Hottinger, A. F.; DeAngelis, L. M.; Lassman, A. B.; Abrey, L. E.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • A randomized phase II trial of concurrent temozolomide (TMZ) and radiotherapy (RT) followed by dose dense compared to metronomic TMZ and maintenance cis-retinoic acid for patients with newly diagnosed glioblastoma multiforme (GBM)
    Meeting Abstract

    Sul, J.; Panageas, K. S.; Lassman, A. B.; Hormigo, A.; Nolan, C.; Gavrilovic, I. T.; Grimm, S. A.; DeAngelis, L. M.; Abrey, L. E.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • A phase II trial of temozolomide and vinorelbine for patients with recurrent brain metastases
    Meeting Abstract

    Iwamoto, F. M.; Omuro, A. M.; Raizer, J. J.; Nolan, C. P.; Hormigo, A.; Lassman, A. B.; Gavrilovic, I. T.; Abrey, L. E.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Clinical and molecular-metabolic phase II trial of perifosine for recurrent/progressive malignant glioma
    Meeting Abstract

    Lassman, A.; Holland, E.; DeAngelis, L.; Panageas, K.; Abrey, L.
    Neuro-Oncology (2007)

    Fulltext@MSK | Save
  • Tumor tissue delivery of cilengitide after intravenous administration to patients with recurrent glioblastoma (GBM): Preliminary data from NABTC protocol 03-02
    Meeting Abstract

    Gilbert, M.; Lamborn, K.; Lassman, A.; Cloughesy, T.; Chang, S.; Lieberman, F.; Wen, P.; Potzsch, S.; Picard, M.; Prados, M.; more...
    Neuro-Oncology (2007)

    Fulltext@MSK | Save
  • A randomized phase II trial of concurrent temozolomide (TMZ) and radiotherapy (RT) followed by dose-dense compared to metronomic TMZ and maintenance cis-retinoic acid for patients with newly diagnosed glioblastoma multiforme (GBM)
    Meeting Abstract

    Clarke, J.; Sul, J.; DeAngelis, L.; Lassman, A.; Hormigo, A.; Nolan, C.; Gavrilovic, I.; Gu, B.; Panageas, K.; Abrey, L.
    Neuro-Oncology (2007)

    Fulltext@MSK | Save
  • Myelosuppression in patients benefiting from imatinib with hydroxyurea for recurrent malignant gliomas
    Journal Article

    Shah, G. D.; Silver, J. S.; Rosenfeld, S. S.; Gavrilovic, I. T.; Abrey, L. E.; Lassman, A. B.
    Journal of Neuro-Oncology (2007)

    Fulltext@MSK | Save
  • Incorporating molecular tools into clinical trials and treatment for gliomas?
    Journal Article

    Lassman, A. B.; Holland, E. C.
    Current Opinion in Neurology (2007)

    Fulltext@MSK | Save
  • Should patients with anaplastic oligodendroglial tumors receive adjuvant chemotherapy? Commentary
    Journal Article

    Lassman, A. B.; Abrey, L. E.
    Nature Clinical Practice Oncology (2007)

    Fulltext@MSK | Save